PICTET ASSET MANAGEMENT LTD - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 383 filers reported holding NEKTAR THERAPEUTICS in Q2 2018. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
PICTET ASSET MANAGEMENT LTD ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q2 2021$199,000
-32.3%
11,600
-21.1%
0.00%
Q1 2021$294,000
-74.6%
14,700
-78.4%
0.00%
-100.0%
Q4 2020$1,159,000
+2.5%
68,1930.0%0.00%0.0%
Q3 2020$1,131,000
-56.5%
68,193
-39.2%
0.00%
-50.0%
Q2 2020$2,599,000
-10.5%
112,236
-31.0%
0.00%
-33.3%
Q1 2020$2,905,000
+53.0%
162,760
+85.0%
0.01%
+100.0%
Q4 2019$1,899,000
-77.0%
87,960
-80.6%
0.00%
-66.7%
Q3 2019$8,274,000
+2.9%
454,242
+101.0%
0.01%
-47.1%
Q2 2019$8,042,000
+183.6%
226,021
+167.8%
0.02%
+183.3%
Q1 2019$2,836,000
+14.3%
84,400
+11.8%
0.01%0.0%
Q4 2018$2,482,000
-86.6%
75,500
-75.2%
0.01%
-84.6%
Q3 2018$18,560,000
-23.4%
304,462
-38.6%
0.04%
-32.8%
Q2 2018$24,223,000
-53.4%
496,061
+1.5%
0.06%
-54.7%
Q1 2018$51,950,000
+3453.4%
488,894
+702.8%
0.13%
+3100.0%
Q3 2017$1,462,000
-27.0%
60,900
-39.5%
0.00%
-33.3%
Q2 2017$2,002,000
-10.6%
100,700
+5.6%
0.01%
-14.3%
Q1 2017$2,239,000
+23.4%
95,400
-35.5%
0.01%0.0%
Q4 2016$1,815,000147,9000.01%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q2 2018
NameSharesValueWeighting ↓
Camber Capital Management LP 2,000,000$67,200,0003.35%
First Light Asset Management, LLC 763,403$25,650,0003.33%
BRIDGER MANAGEMENT, LLC 1,238,489$41,613,0003.29%
Rhenman & Partners Asset Management AB 734,445$24,677,0002.89%
BB BIOTECH AG 2,020,676$67,895,0001.71%
Gs Investments, Inc. 54,200$1,821,120,0001.43%
Artal Group S.A. 900,000$30,240,0001.24%
Cormorant Asset Management, LP 500,000$16,800,0001.14%
TOBAM 640,547$21,522,0001.09%
Bellevue Group AG 430,026$14,449,0000.80%
View complete list of NEKTAR THERAPEUTICS shareholders